Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
The Journal of Biological Chemistry
|
August 4, 1995
Pharmacological and biochemical profiles of unique neurotensin 8-13 analogs exhibiting species selectivity, stereoselectivity, and superagonism
B Cusack, D J McCormick, Y P Pang, et al.
Journal of Environmental Management
|
April 23, 2019
The use of rapid, small-scale column tests to determine the efficiency of bauxite residue as a low-cost adsorbent in the removal of dissolved reactive phosphorus from agricultural waters
Patricia B Cusack, Oisín Callery, Ronan Courtney, et al.
Journal of Neurochemistry
|
November 1, 1992
The rat neurotensin receptor expressed in Chinese hamster ovary cells mediates the release of inositol phosphates
M A Watson, M Yamada, M Yamada, et al.
Molecular Pharmacology
|
January 29, 2000
Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease
P Camps, B Cusack, W D Mallender, et al.
The Journal of Biological Chemistry
|
June 21, 1996
Chimeric rat/human neurotensin receptors localize a region of the receptor sensitive to binding of a novel, species-specific, picomolar affinity peptide
B Cusack, K Groshan, D J McCormick, et al.
Neuropharmacology
|
July 31, 1999
In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier
B M Tyler, C L Douglas, A Fauq, et al.
FEBS Letters
|
February 19, 1998
Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo
B M Tyler, D J McCormick, C V Hoshall, et al.
Genome Research
|
December 4, 2001
Advanced integrated mouse YAC map including BAC framework
L C Schalkwyk, B Cusack, I Dunkel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 9, 1999
Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression
B M Tyler, K Jansen, D J McCormick, et al.
Journal of Paediatrics and Child Health
|
February 10, 2021
Paediatric genomic testing: Navigating medicare rebatable genomic testing
Rani Sachdev, Mike Field, Gareth S Baynam, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
The Journal of Biological Chemistry
|
August 4, 1995
Pharmacological and biochemical profiles of unique neurotensin 8-13 analogs exhibiting species selectivity, stereoselectivity, and superagonism
B Cusack, D J McCormick, Y P Pang, et al.
Journal of Environmental Management
|
April 23, 2019
The use of rapid, small-scale column tests to determine the efficiency of bauxite residue as a low-cost adsorbent in the removal of dissolved reactive phosphorus from agricultural waters
Patricia B Cusack, Oisín Callery, Ronan Courtney, et al.
Journal of Neurochemistry
|
November 1, 1992
The rat neurotensin receptor expressed in Chinese hamster ovary cells mediates the release of inositol phosphates
M A Watson, M Yamada, M Yamada, et al.
Molecular Pharmacology
|
January 29, 2000
Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease
P Camps, B Cusack, W D Mallender, et al.
The Journal of Biological Chemistry
|
June 21, 1996
Chimeric rat/human neurotensin receptors localize a region of the receptor sensitive to binding of a novel, species-specific, picomolar affinity peptide
B Cusack, K Groshan, D J McCormick, et al.
Neuropharmacology
|
July 31, 1999
In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier
B M Tyler, C L Douglas, A Fauq, et al.
FEBS Letters
|
February 19, 1998
Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo
B M Tyler, D J McCormick, C V Hoshall, et al.
Genome Research
|
December 4, 2001
Advanced integrated mouse YAC map including BAC framework
L C Schalkwyk, B Cusack, I Dunkel, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 9, 1999
Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression
B M Tyler, K Jansen, D J McCormick, et al.
Journal of Paediatrics and Child Health
|
February 10, 2021
Paediatric genomic testing: Navigating medicare rebatable genomic testing
Rani Sachdev, Mike Field, Gareth S Baynam, et al.
Page
of 5